EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TESTPRNewsWire • 05/18/23
BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEMPRNewsWire • 05/16/23
BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCEPRNewsWire • 05/12/23
BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNAPRNewsWire • 05/10/23
BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCEPRNewsWire • 04/13/23
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSPRNewsWire • 04/12/23
BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA™ INSTRUMENTS NOW IN OPERATIONPRNewsWire • 04/05/23
Increase': "Immunoassay Market Soars to New Heights, Predicted to Surpass USD 51.95 Billion by 2030 with a Strong CAGRGlobeNewsWire • 03/29/23
BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUMPRNewsWire • 03/15/23